Top Abstract Purchase Related
Home
>
Node
>
Subnode

Antinuclear antibodies in ankylosing spondylitis

Prohaska, E.; Neumüller, J.; Partsch, G.; Eberl, R.

Wiener Klinische Wochenschrift 92(24): 876-879

1980

ISSN/ISBN: 0043-5325
PMID: 6971529
Document Number: 164463
Antinuclear antibodies (ANA) were found in 19.1% of patients suffering from ankylosing spondylitis (n = 320). This figure is significantly higher than the results obtained in a control group. ANA were present in all stages of the disease, including the abortive form of isolated sacroiliitis. ANA were also found in different stages of activity. In addition, ANA-positive cases showed a higher inflammatory activity. In females ANA were more frequently found than in males. There was a positive correlation between ANA and HLA B27 in 87.2%.

Document emailed within 1 workday
Secure & encrypted payments

Vasey, F.B.; Kinsella, T.D. 1977: Increased frequency of leukocyte-reactive antinuclear antibody in patients with ankylosing spondylitis Journal of Rheumatology 4(2): 158-164
Grazio, S.; Grubisić, F.; Nemcić, T.; Matijević, V.; Skala, H. 2009: The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis Reumatizam 56(2): 63-76
Sieper, J.; Braun, J. 2002: New treatment strategies in ankylosing spondylitis: Proceedings of the Ankylosing Spondylitis Workshop, Berlin, Germany, 18-19 January 2002 Annals of the Rheumatic Diseases 61 Suppl. 3: Iii1-Iii2
Villa Alcázar, L.F.; de Buergo, M.; Rico Lenza, H.; Montull Fruitós, E. 1996: Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis Journal of Rheumatology 23(7): 1194-1199
Kim, T.-J.; Shin, J.-H.; Sung, I.-H.; Lee, S.; Song, Y.; Kim, T.-H. 2016: Comparison on radiographic progression for 5 years between juvenile onset ankylosing spondylitis and adult onset ankylosing spondylitis: an observational study of the Korean SpondyloArthropathy Registry (OSKAR) data Clinical and Experimental Rheumatology 34(4): 668-672
Hrncír, Z.; Nozicka, Z.; Bradna, P. 1988: Antibodies to brush-border antigens in ankylosing spondylitis Casopis Lekaru Ceskych 127(3): 84-85
Calin, A.; Garrett, S.; Whitelock, H.; Kennedy, L.G.; O'Hea, J.; Mallorie, P.; Jenkinson, T. 1994: A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index Journal of Rheumatology 21(12): 2281-2285
Yuan, G.; Shi, G.; Ding, Y. 1995: Serum anti-subtypical Klebsiella pneumoniae antibodies in ankylosing spondylitis Zhonghua Nei Ke Za Zhi 34(3): 193-195
Heldmann, F.; Brandt, J.; van der Horst-Bruinsma, I.E.; Landewe, R.; Sieper, J.; Burmester, G.R.; van den Bosch, F.; de Vlam, K.; Geusens, P.; Gaston, H.; Schewe, S.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M.; Listing, J.; Braun, J. 2011: The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab Clinical and Experimental Rheumatology 29(4): 672-680
Chen, C.S.; Shi, G.Y. 1994: Detection of serum anti-histone antibodies in patients with ankylosing spondylitis and its clinical significance Zhonghua Nei Ke Za Zhi 33(6): 382-384
Domínguez-López, M.L.; Ortega-Ortega, Y.; Manríquez-Raya, J.C.; Burgos-Vargas, R.; Vega-López, A.; García-Latorre, E. 2009: Antibodies against recombinant heat shock proteins of 60 kDa from enterobacteria in the sera and synovial fluid of HLA-B27 positive ankylosing spondylitis patients Clinical and Experimental Rheumatology 27(4): 626-632
Mäki-Ikola, O.; Lehtinen, K.; Toivanen, P.; Granfors, K. 1995: Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of ankylosing spondylitis patients with/without iritis and enthesitis British Journal of Rheumatology 34(5): 418-420
Menkes, C.J.; Kahan, A.; Feldmann, J.L.; Vinh, T. 1983: Destructive cervical spondylitis. An unusual initial manifestation of ankylosing spondylitis Presse Medicale 12(4): 227-229
Le Goff, P.; Muller, S.; Lelong, A.; Jouquan, J.; Youinou, P. 1988: Among the antinuclear antibodies in rheumatoid polyarthritis: antihistone antibodies detected by an immunoenzymatic technic Revue du Rhumatisme et des Maladies Osteo-Articulaires 55(11): 919-922
Saraux, A. 2011: Ankylosing spondylitis La Revue du Praticien 61(7): 999-1006
Jajić, Z. 2000: Ankylosing spondylitis Reumatizam 47(2): 18-19
Costa, T.; Falcão, S.; Mateus, M.; Branco, J. 2018: More than Ankylosing Spondylitis Acta Reumatologica Portuguesa 2018
Wojas-Pelc, A.; Wielowieyska-Szybińska, D.; Kiełtyka, A. 2002: Presence of the antinuclear antibodies and antibodies to Borrelia burgdorferi among patients with morphea en plaque, deep linear scleroderma and atrophoderma Pasini-Pierini Przeglad Lekarski 59(11): 898-902
Calin, A.; Edmunds, L.; Kennedy, L.G. 1993: Fatigue in ankylosing spondylitis--why is it ignored? Journal of Rheumatology 20(6): 991-995
Fassbender, H.G. 1975: Pathology of ankylosing spondylitis Die Medizinische Welt 26(45): 2039